Evidence map›Paper›PMID 38297498›Full record

ArticleBJPsych open2024

Evaluation of the psychometrics of the Social Impact Scale and its association with depression among asymptomatic COVID-19 carriers.

Rongxi Wang, Zuxin Wang, Dake Shi, Liling Xu, Yujie Liu, Shangbin Liu, Hui Chen, Yingjie Chen, Danni Xia, Xin Ge and 8 more

Abstract read
In one paragraph

Article in BJPsych open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Rongxi WangPublic Health Department, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, China; Department of Scientific Research and Disciplinary Development, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, China; and School of Public Health, Shanghai Jiao Tong University School of Medicine, China.
Zuxin WangSchool of Public Health, Shanghai Jiao Tong University School of Medicine, China.
Dake ShiSchool of Public Health, Shanghai Jiao Tong University School of Medicine, China; and Department of Infection Control, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China.
Liling XuPublic Health Department, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, China.
Yujie LiuSchool of Public Health, Shanghai Jiao Tong University School of Medicine, China.
Shangbin LiuSchool of Public Health, Shanghai Jiao Tong University School of Medicine, China.
Hui ChenSchool of Public Health, Shanghai Jiao Tong University School of Medicine, China.
Yingjie ChenSchool of Public Health, Shanghai Jiao Tong University School of Medicine, China.
Danni XiaSchool of Public Health, Shanghai Jiao Tong University School of Medicine, China.
Xin GeSchool of Public Health, Shanghai Jiao Tong University School of Medicine, China.
Huifang XuSchool of Public Health, Shanghai Jiao Tong University School of Medicine, China.
Yufei ChenSchool of Public Health, Shanghai Jiao Tong University School of Medicine, China.
Zhiqiang WangSchool of Public Health, Shanghai Jiao Tong University School of Medicine, China.
Ruijie ChangPublic Health Department, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, China; and Center for Community Health Care, Hospital Development Institute Shanghai Jiao Tong University, China.
Fan HuPublic Health Department, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, China; and Center for Community Health Care, Hospital Development Institute Shanghai Jiao Tong University, China.
Tian ShenPublic Health Department, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, China; and Center for Community Health Care, Hospital Development Institute Shanghai Jiao Tong University, China.
Ying WangPublic Health Department, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, China; and Center for Community Health Care, Hospital Development Institute Shanghai Jiao Tong University, China.
Yong CaiPublic Health Department, Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, China; and Center for Community Health Care, Hospital Development Institute Shanghai Jiao Tong University, China.ORCID https://orcid.org/0000-0002-5706-7906

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 carriers experience psychological stresses and mental health issues such as varying degrees of stigma. The Social Impact Scale (SIS) can be used to measure the stigmatisation of COVID-19 carriers who experience such problems.

aimsTo evaluate the reliability and validity of the Chinese version of the SIS, and the association between stigma and depression among asymptomatic COVID-19 carriers in Shanghai, China.

methodA total of 1283 asymptomatic COVID-19 carriers from Shanghai Ruijin Jiahe Fangcang Shelter Hospital were recruited, with a mean age of 39.64 ± 11.14 years (59.6% male). Participants completed questionnaires, including baseline information and psychological measurements, the SIS and Self-Rating Depression Scale. The psychometrics of the SIS and its association with depression were examined through exploratory factor analysis, confirmatory factor analysis and receiver operating characteristic analysis.

resultsThe average participant SIS score was 42.66 ± 14.61 (range: 24-96) years. Analyses suggested the model had four factors: social rejection, financial insecurity, internalised shame and social isolation. The model fit statistics of the four-factor SIS were 0.913 for the comparative fit index, 0.902 for the Tucker-Lewis index and 0.088 for root-mean-square error of approximation. Standard estimated factor loadings ranged from 0.509 to 0.836. After controlling for demographic characteristics, the total score of the 23-item SIS predicted depression (odds ratio: 1.087, 95% CI 1.061-1.115; area under the curve: 0.84, 95% CI 0.788-0.892).

conclusionsThe Chinese version of the SIS showed good psychometric properties and can be used to assess the level of perceived stigma experienced by asymptomatic COVID-19 carriers.

Indexed as

asymptomatic COVID-19 carrierconfirmatory factor analysisdepressionSocial Impact ScaleStigma

Identifiers

PMID38297498
PMCPMC10897691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.